 Marta Ceko
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chronic Pain | 11 | 2024 | 291 | 2.260 |
Why?
| | Fibromyalgia | 8 | 2021 | 52 | 1.850 |
Why?
| | Cognition | 7 | 2025 | 1268 | 1.330 |
Why?
| | Cerebral Cortex | 5 | 2020 | 471 | 1.250 |
Why?
| | Brain Mapping | 7 | 2024 | 536 | 1.080 |
Why?
| | Magnetic Resonance Imaging | 16 | 2024 | 3897 | 1.080 |
Why?
| | Brain | 9 | 2025 | 2944 | 1.030 |
Why?
| | Pain | 6 | 2022 | 787 | 0.960 |
Why?
| | Pain Measurement | 6 | 2024 | 558 | 0.860 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2024 | 70 | 0.820 |
Why?
| | Virtual Reality Exposure Therapy | 1 | 2024 | 8 | 0.820 |
Why?
| | Back Pain | 1 | 2024 | 53 | 0.790 |
Why?
| | Reading | 1 | 2024 | 135 | 0.770 |
Why?
| | Connectome | 2 | 2021 | 93 | 0.610 |
Why?
| | Healthy Volunteers | 3 | 2020 | 218 | 0.600 |
Why?
| | Neural Pathways | 5 | 2021 | 312 | 0.500 |
Why?
| | Memory, Short-Term | 2 | 2016 | 272 | 0.470 |
Why?
| | Nociception | 2 | 2024 | 17 | 0.470 |
Why?
| | Low Back Pain | 2 | 2021 | 106 | 0.430 |
Why?
| | Placebo Effect | 3 | 2024 | 25 | 0.410 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 198 | 0.410 |
Why?
| | Memory Disorders | 1 | 2015 | 198 | 0.410 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2014 | 72 | 0.400 |
Why?
| | Nerve Net | 2 | 2021 | 284 | 0.390 |
Why?
| | Benzamides | 1 | 2014 | 224 | 0.380 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 127 | 0.380 |
Why?
| | Polyradiculopathy | 1 | 2012 | 3 | 0.370 |
Why?
| | Cold Temperature | 1 | 2014 | 209 | 0.370 |
Why?
| | Prefrontal Cortex | 3 | 2024 | 334 | 0.360 |
Why?
| | Nerve Fibers | 1 | 2012 | 105 | 0.350 |
Why?
| | Analgesia | 3 | 2024 | 106 | 0.350 |
Why?
| | Piperazines | 1 | 2014 | 378 | 0.340 |
Why?
| | Hot Temperature | 1 | 2014 | 411 | 0.330 |
Why?
| | Pyrimidines | 1 | 2014 | 520 | 0.310 |
Why?
| | Pain Threshold | 3 | 2014 | 72 | 0.300 |
Why?
| | Emotions | 3 | 2021 | 579 | 0.270 |
Why?
| | Neuroimaging | 2 | 2024 | 293 | 0.270 |
Why?
| | Pain Perception | 4 | 2014 | 24 | 0.250 |
Why?
| | Adult | 16 | 2024 | 40707 | 0.250 |
Why?
| | Touch | 2 | 2016 | 39 | 0.210 |
Why?
| | Nociceptive Pain | 1 | 2024 | 4 | 0.210 |
Why?
| | Affect | 3 | 2024 | 322 | 0.210 |
Why?
| | Catastrophization | 1 | 2024 | 16 | 0.210 |
Why?
| | Humans | 28 | 2025 | 145491 | 0.210 |
Why?
| | Middle Aged | 11 | 2024 | 36176 | 0.200 |
Why?
| | Neurosciences | 1 | 2024 | 23 | 0.200 |
Why?
| | Female | 19 | 2024 | 78763 | 0.200 |
Why?
| | Young Adult | 9 | 2024 | 14192 | 0.190 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2207 | 0.180 |
Why?
| | Comprehension | 1 | 2024 | 184 | 0.180 |
Why?
| | Virtual Reality | 1 | 2024 | 82 | 0.180 |
Why?
| | Hypothalamus, Posterior | 1 | 2021 | 3 | 0.180 |
Why?
| | Pulvinar | 1 | 2021 | 3 | 0.170 |
Why?
| | Escape Reaction | 1 | 2021 | 55 | 0.170 |
Why?
| | Periaqueductal Gray | 1 | 2021 | 37 | 0.170 |
Why?
| | Male | 15 | 2024 | 72817 | 0.170 |
Why?
| | Superior Colliculi | 1 | 2021 | 44 | 0.160 |
Why?
| | Functional Neuroimaging | 1 | 2021 | 60 | 0.160 |
Why?
| | Deception | 1 | 2020 | 18 | 0.160 |
Why?
| | Amygdala | 1 | 2021 | 199 | 0.150 |
Why?
| | Disclosure | 1 | 2020 | 84 | 0.150 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2018 | 780 | 0.150 |
Why?
| | Visual Analog Scale | 1 | 2018 | 34 | 0.140 |
Why?
| | Gray Matter | 2 | 2016 | 92 | 0.140 |
Why?
| | Fear | 1 | 2021 | 367 | 0.130 |
Why?
| | Behavior, Animal | 1 | 2021 | 526 | 0.130 |
Why?
| | Diffusion Tensor Imaging | 2 | 2015 | 75 | 0.130 |
Why?
| | Attitude to Health | 1 | 2020 | 431 | 0.120 |
Why?
| | Sensation Disorders | 1 | 2016 | 42 | 0.120 |
Why?
| | Proprioception | 1 | 2016 | 34 | 0.120 |
Why?
| | Central Nervous System Sensitization | 1 | 2016 | 5 | 0.120 |
Why?
| | Touch Perception | 1 | 2016 | 17 | 0.120 |
Why?
| | Ion Channels | 1 | 2016 | 129 | 0.120 |
Why?
| | Multimodal Imaging | 1 | 2016 | 129 | 0.120 |
Why?
| | Gene Silencing | 1 | 2016 | 202 | 0.110 |
Why?
| | Receptors, Opioid, mu | 1 | 2016 | 66 | 0.110 |
Why?
| | Cognitive Reserve | 1 | 2015 | 15 | 0.110 |
Why?
| | Zygapophyseal Joint | 1 | 2015 | 8 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2024 | 11831 | 0.110 |
Why?
| | Rest | 1 | 2015 | 124 | 0.100 |
Why?
| | Pain Management | 2 | 2021 | 411 | 0.100 |
Why?
| | Imatinib Mesylate | 1 | 2014 | 77 | 0.100 |
Why?
| | Spine | 1 | 2015 | 182 | 0.100 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2012 | 8 | 0.100 |
Why?
| | Yoga | 1 | 2013 | 31 | 0.100 |
Why?
| | Skin | 2 | 2014 | 766 | 0.090 |
Why?
| | Neurons, Afferent | 1 | 2012 | 102 | 0.090 |
Why?
| | Hyperalgesia | 1 | 2012 | 132 | 0.090 |
Why?
| | Cognition Disorders | 1 | 2016 | 541 | 0.090 |
Why?
| | Dopamine | 1 | 2013 | 295 | 0.080 |
Why?
| | Case-Control Studies | 2 | 2020 | 3619 | 0.080 |
Why?
| | Qualitative Research | 1 | 2018 | 1677 | 0.080 |
Why?
| | Neuronal Plasticity | 1 | 2012 | 306 | 0.070 |
Why?
| | Biomarkers | 1 | 2021 | 4283 | 0.070 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 6070 | 0.070 |
Why?
| | Naloxone | 2 | 2021 | 132 | 0.060 |
Why?
| | Models, Neurological | 2 | 2021 | 250 | 0.060 |
Why?
| | Physical Stimulation | 2 | 2016 | 68 | 0.050 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1058 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 426 | 0.050 |
Why?
| | Analgesics | 1 | 2024 | 233 | 0.050 |
Why?
| | Cholecystokinin | 1 | 2021 | 15 | 0.040 |
Why?
| | Oxygen | 2 | 2018 | 986 | 0.040 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 128 | 0.040 |
Why?
| | Aversive Agents | 1 | 2021 | 1 | 0.040 |
Why?
| | Facial Pain | 1 | 2021 | 12 | 0.040 |
Why?
| | Capsaicin | 1 | 2021 | 30 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2021 | 264 | 0.040 |
Why?
| | Signal Transduction | 1 | 2014 | 5202 | 0.040 |
Why?
| | Video Recording | 1 | 2021 | 218 | 0.040 |
Why?
| | Optogenetics | 1 | 2021 | 103 | 0.040 |
Why?
| | Animals | 3 | 2021 | 38141 | 0.040 |
Why?
| | Visual Perception | 1 | 2021 | 185 | 0.040 |
Why?
| | Taste | 1 | 2021 | 241 | 0.030 |
Why?
| | Genomics | 1 | 2023 | 834 | 0.030 |
Why?
| | Aged | 2 | 2016 | 26125 | 0.030 |
Why?
| | Adolescent | 4 | 2021 | 22485 | 0.030 |
Why?
| | Flumazenil | 1 | 2016 | 8 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2018 | 171 | 0.030 |
Why?
| | Body Water | 1 | 2016 | 23 | 0.030 |
Why?
| | Brain Chemistry | 1 | 2016 | 117 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1378 | 0.030 |
Why?
| | Vibration | 1 | 2016 | 71 | 0.030 |
Why?
| | Vulvodynia | 1 | 2016 | 2 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2189 | 0.030 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2016 | 19 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 2002 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2016 | 207 | 0.030 |
Why?
| | Irritable Bowel Syndrome | 1 | 2016 | 29 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2016 | 137 | 0.030 |
Why?
| | Mechanotransduction, Cellular | 1 | 2016 | 120 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2129 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2016 | 186 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2016 | 343 | 0.030 |
Why?
| | Postmenopause | 1 | 2016 | 391 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1896 | 0.030 |
Why?
| | Sulpiride | 1 | 2013 | 5 | 0.030 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2013 | 5 | 0.030 |
Why?
| | Thermosensing | 1 | 2013 | 12 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 625 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 743 | 0.030 |
Why?
| | Narcotic Antagonists | 1 | 2016 | 204 | 0.020 |
Why?
| | Phenylalanine | 1 | 2013 | 70 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 831 | 0.020 |
Why?
| | Tyrosine | 1 | 2013 | 219 | 0.020 |
Why?
| | Receptors, Dopamine D2 | 1 | 2013 | 93 | 0.020 |
Why?
| | Presynaptic Terminals | 1 | 2013 | 89 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5581 | 0.020 |
Why?
| | Mice | 2 | 2021 | 18338 | 0.020 |
Why?
| | White Matter | 1 | 2013 | 153 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1139 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5989 | 0.020 |
Why?
| | Time Factors | 1 | 2021 | 7171 | 0.020 |
Why?
| | Attention | 1 | 2013 | 463 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2820 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3157 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2945 | 0.020 |
Why?
| | Anxiety | 1 | 2013 | 1127 | 0.010 |
Why?
| | Child | 1 | 2016 | 22680 | 0.010 |
Why?
|
|
Ceko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|